Derek J. Bell

Derek J. Bell serves as a key procurement professional within the Naval Medical Logistics Command, supporting the acquisition of mission-critical medical systems essential to Navy and Marine Corps operational readiness. He manages complex contracting actions for advanced diagnostic, laboratory, and surgical equipment, ensuring timely delivery of life-sustaining medical technologies to global deployment theaters. His work directly enables combat casualty care and point-of-care diagnostics by securing high-precision instruments that meet stringent military specifications and regulatory standards. Bell’s portfolio emphasizes end-to-end logistics sustainment, from initial procurement through lifecycle support, aligning with the Command’s strategic focus on modernizing medical logistics infrastructure. His contractor relationships are primarily with manufacturers and specialty suppliers of analytical, electromedical, and in-vitro diagnostic systems. While no single vendor dominates his acquisition portfolio, he routinely engages with mid- to large-scale industrial firms capable of meeting DoD quality assurance requirements, including ISO 13485 certification and FDA-compliant production controls. His contracting approach prioritizes technical capability, supply chain resilience, and compliance with military standards such as MIL-STD-810 and MIL-PRF-38534, fostering long-term partnerships with vendors who demonstrate proven performance in austere environments. Bell’s procurement activities reflect a strong preference for open competition, with 100% of his acquisitions conducted under non-set-aside authorities. This indicates a focus on technical merit and capability over socioeconomic categorization, though he remains compliant with all federal small business participation requirements. His approach prioritizes mission need over socioeconomic preferences, ensuring the most technically suitable solutions are selected without artificial constraints. His primary procurement focus lies in NAICS 334516 (analytical laboratory instruments), 339112 (surgical and medical instruments), and 325413 (in-vitro diagnostic substances), reflecting deep expertise in clinical diagnostics, precision medical devices, and laboratory automation. He routinely acquires mass spectrometers, portable analyzers, sterilization systems, and reagent kits, demonstrating specialized knowledge in biomedical engineering and diagnostic technology domains.